SAN CARLOS, Calif. (AP) _ Iovance Biotherapeutics Inc. (IOVA) on Thursday reported a loss of $58.6 million in its third quarter.

The San Carlos, California-based company said it had a loss of 40 cents per share.

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 46 cents per share.

Iovance Biotherapeutics shares have risen 46% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $40.42, a climb of 85% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News